|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Radiation Oncology Journal
Search
> Browse Articles > Search
Clinical Investigations
I
n
v
i
v
o
d
o
s
i
m
e
t
r
y
a
n
d
a
c
u
t
e
t
o
x
i
c
i
t
y
i
n
b
r
e
a
s
t
c
a
n
c
e
r
p
a
t
i
e
n
t
s
u
n
d
e
r
g
o
i
n
g
i
n
t
r
a
o
p
e
r
a
t
i
v
e
r
a
d
i
o
t
h
e
r
a
p
y
a
s
b
o
o
s
t
J
a
s
o
n
J
o
o
n
B
o
c
k
L
e
e
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
J
i
n
h
y
u
n
C
h
o
i
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
S
u
n
g
G
w
e
A
h
n
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
J
o
o
n
J
e
o
n
g
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
I
k
J
a
e
L
e
e
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
K
w
a
n
g
w
o
o
P
a
r
k
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
K
a
n
g
p
y
o
K
i
m
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
,
J
u
n
W
o
n
K
i
m
<
i
m
g
s
r
c
=
'
/
i
m
a
g
e
/
f
l
a
g
/
k
r
.
g
i
f
'
s
t
y
l
e
=
'
w
i
d
t
h
:
2
1
p
x
;
h
e
i
g
h
t
:
1
3
p
x
;
m
a
r
g
i
n
-
t
o
p
:
4
p
x
;
m
a
r
g
i
n
-
l
e
f
t
:
5
p
x
;
v
e
r
t
i
c
a
l
-
a
l
i
g
n
:
t
e
x
t
-
t
o
p
;
'
c
l
a
s
s
=
'
i
m
g
_
a
'
>
Radiat Oncol J.
2017;35(2):121-128. Published online 2017 Jun 30 DOI:
https://doi.org/10.3857/roj.2017.00150
Full text
PubReader
ePub
PDF
Web of Science 17
Crossref 18
T
h
e
R
e
s
u
l
t
s
o
f
I
n
t
r
a
o
p
e
r
a
t
i
v
e
R
a
d
i
o
t
h
e
r
a
p
y
f
o
r
S
t
o
m
a
c
h
C
a
n
c
e
r
J
i
H
o
o
n
C
h
o
i
,
M
i
n
K
y
u
K
a
n
g
,
M
y
u
n
g
S
e
K
i
m
,
S
u
n
g
K
y
u
K
i
m
,
S
a
n
g
M
o
Y
u
n
,
S
u
n
g
H
o
o
n
K
i
m
J Korean Soc Ther Radiol Oncol.
2010;28(2):79-84. DOI:
https://doi.org/10.3857/jkstro.2010.28.2.79
PDF
T
h
e
d
o
s
i
m
e
t
r
i
c
P
r
o
p
e
r
t
i
e
s
o
f
E
l
e
c
t
r
o
n
B
e
a
m
U
s
i
n
g
L
y
o
n
I
n
t
r
a
o
p
e
r
a
t
i
v
e
D
e
v
i
c
e
f
o
r
I
n
t
r
a
o
p
e
r
a
t
i
v
e
R
a
d
i
a
t
i
o
n
T
h
e
r
a
p
y
K
y
e
J
u
n
K
i
m
,
K
y
u
n
g
R
a
n
P
a
r
k
,
J
o
n
g
Y
o
u
n
g
L
e
e
,
H
i
e
Y
e
o
n
K
i
m
,
K
i
J
o
o
n
S
u
n
g
,
S
u
n
g
S
i
l
C
h
u
J Korean Soc Ther Radiol.
1992;10(1):85-94.
PDF
I
n
t
r
a
o
p
e
r
a
t
i
v
e
R
a
d
i
o
t
h
e
r
a
p
y
(
I
O
R
T
)
f
o
r
L
o
c
a
l
l
y
A
d
v
a
n
c
e
d
C
o
l
o
r
e
c
t
a
l
C
a
n
c
e
r
M
y
u
n
g
S
e
K
i
m
,
S
u
n
g
K
y
u
K
i
m
,
J
a
e
H
w
a
n
g
K
i
m
,
K
o
i
n
g
B
o
K
w
a
n
,
H
e
u
n
g
D
a
e
K
i
m
J Korean Soc Ther Radiol.
1991;9(2):265-270.
PDF
1
|
Journal Impact Factor 1.8